To determine the pathogenic role of elevated IGFBP5, we established transgenic mouse lines in which IGFBP5 is overexpressed specifically in neurons under the control of the neurofilament-light chain (NF-L) promoter and found a progressive neuropathy in these mutants that affected both sensory and motor nerve fibers. This evidence concerns the gene IGFBP5 and neuropathy.